21 completed, 3 terminated. 24 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 24 | Completed 21, Terminated 3 |
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow Omacor: new trials by email Literature Review of Omacor trials Research Report on Omacor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunonutrition for Diabetic Foot Ulcers Lovaza, L-Arginine Powder, Vitamin C - Diabetes Mellitus, Diabetic Peripheral Neuropathy | Phase 2 / Phase 3 | Terminated | Prisma Health-Midlands | 1 | 2023-02-08 | 2024-12-27 |
| The Long-term Effect of Marine Omega-3 Fatty Acid Supplementation in Renal Transplantation Omacor, Placebo Oral Capsule - Kidney Transplantation | Phase 3 | Completed | Joe Chan | 174 | 2017-09-01 | 2025-04-03 |
| Effect of Omega-3 Fatty Acid on Endothelial Function Omega-3, placebo - Familial Hypercholesterolemia | Phase 3 | Completed | Nordlandssykehuset HF | 34 | 2013-03-01 | 2019-05-13 |
| Omega-3 Fatty Acids and Insulin Sensitivity Omega-3, placebo - Insulin Resistance | Phase 3 | Completed | Mayo Clinic | 31 | 2012-12-21 | 2017-03-03 |
| Study of Vitamin D and Omega-3 Supplementation for Preventing Diabetes Vitamin D3, Omega-3 fatty acid (fish oil), Vitamin D3 placebo - Type 2 Diabetes | Phase 3 | Completed | Brigham and Women's Hospital | 22220 | 2011-11-01 | 2026-04-03 |
| An Efficacy and Safety Study of Omacor® in Taiwanese Hypertriglyceridemic Patients Omacor®, Placebo - Hypertriglyceridemia | Phase 3 | Completed | Excelsior | 253 | 2011-07-01 | 2014-05-19 |
| OMEGA-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Peripheral Arterial Disease OMACOR, Placebo - Peripheral Arterial Disease | Phase 3 | Completed | Medical University of Vienna | 71 | 2011-01-01 | 2014-08-26 |
| The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease Omacor, lactose tablet - Non Alcoholic Fatty Liver Disease | Phase 3 | Completed | University of Edinburgh | 50 | 2010-09-01 | 2014-01-23 |
| Go Fish: Omega-3 Fatty Acid Supplementation in Diabetes-Related Kidney Disease Lovaza (fish oil) - Diabetes | Phase 3 | Completed | Johns Hopkins University | 31 | 2010-03-01 | 2012-04-30 |
| The Effect of Omega-3 Polyunsaturated Fatty Acids in Congestive Heart Failure LOVAZA (Omega-3), Placebo - Heart Failure | Phase 3 | Terminated | Columbia University | 58 | 2010-01-01 | 2016-05-25 |
| Efficacy of TAK-085 in Participants With Hypertriglyceridemia Omega-3-acid ethyl esters 90 (TAK-085), Eicosapentaenoic acid-ethyl (EPA-E) - Hypertriglyceridemia | Phase 3 | Completed | Takeda | 611 | 2009-11-01 | 2016-09-20 |
| Long-term Efficacy and Safety Study of TAK-085 in Participants With Hypertriglyceridemia omega-3-acid ethyl esters 90 (TAK-085), Eicosapentaenoic acid-ethyl (EPA) - Hypertriglyceridemia | Phase 3 | Completed | Takeda | 503 | 2009-11-01 | 2016-09-20 |
| Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries Omega-3, Placebo - Metabolic Diseases, Endocrine System Diseases | Phase 3 | Terminated | Denver Health and Hospital Authority | 76 | 2009-09-01 | 2014-09-29 |
| Fish Oil Study for High Triglyceride Levels in Children Omega-3-acid ethyl esters, Placebo - Hypertriglyceridemia | Phase 2 / Phase 3 | Completed | Babu Balagopal | 42 | 2009-07-01 | 2022-11-08 |
| Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging Omega-3 Fatty Acids (Fish Oil Supplements), Placebo - Myocardial Infarction, Death, Sudden, Cardiac | Phase 3 | Completed | Brigham and Women's Hospital | 358 | 2008-08-01 | 2017-06-01 |
| PUFAs and Left Ventricular Function in Heart Failure n-3 PUFAs, Placebo - Dilated Cardiomyopathy, Heart Failure | Phase 3 | Completed | Università degli Studi di Brescia | 133 | 2007-11-01 | 2012-01-31 |
| Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A Nephropathy Omega-3 fatty acid ethylester90 - IgA Nephropathy | Phase 3 | Completed | Kuhnil Pharmaceutical Co., Ltd. | 152 | 2007-11-01 | 2012-09-27 |
| Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With Hypertriglyceridemia Lovaza (omega-3-acid ethyl esters) [formerly known as Omacor] plus atorvastatin, atorvastatin - Hypertriglyceridemia | Phase 3 | Completed | GlaxoSmithKline | 245 | 2007-02-01 | 2017-02-02 |
| Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation omega-3-acid ethyl esters, Placebo - Fibrillation, Atrial | Phase 3 | Completed | GlaxoSmithKline | 663 | 2006-11-01 | 2017-01-30 |
| n-3 Polyunsaturated Fatty Acids (PUFAs) in the Prevention of Atrial Fibrillation n-3 PUFAs, Placebo, RASS inhibitors and/or RAS blockers - Atrial Fibrillation | Phase 3 | Completed | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 199 | 2006-01-01 | 2012-01-20 |
Showing 20 of 24. Sign in to see all of them.
Hypertriglyceridemia (7) · Diabetes Mellitus (3) · Inflammation (3) · Atrial Fibrillation (2) · Diabetes Mellitus, Type 2 (2) · Heart Failure (2) · Insulin Resistance (2) · Cardiomyopathy, Dilated (1) · Cardiovascular Diseases (1) · Death, Sudden, Cardiac (1) · Diabetic Foot (1) · Dyslipidemias (1) · Endocrine System Diseases (1) · Glomerulonephritis, IGA (1) · Glucose Intolerance (1)
GlaxoSmithKline (4) · Brigham and Women's Hospital (2) · Medical University of Vienna (2) · Takeda (2) · Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (1) · Babu Balagopal (1) · Columbia University (1) · Denver Health and Hospital Authority (1) · Excelsior (1) · Joe Chan (1) · Johns Hopkins University (1) · Kuhnil Pharmaceutical Co., Ltd. (1) · Mayo Clinic (1) · Nordlandssykehuset HF (1) · Prisma Health-Midlands (1)
United States (11) · Austria (3) · Italy (3) · Norway (3) · South Korea (2) · United Kingdom (2) · Argentina (1) · Australia (1) · Belarus (1) · Bermuda (1) · Brazil (1) · Canada (1) · Chile (1) · China (1) · Colombia (1)
Associate Professor, Clinical Cell Biology and Medicine (2) · Livio Dei Cas, MD (2) · Savina Nodari, MD (2) · Aruna Pradhan, MD, MPH (1) · Branimir Draganov, MD (1) · Byung-Joo Park, MD,PhD,FISPE (1) · Carlin S Long, MD (1) · Chuen-Den Tseng, M.D., PhD. (1) · Edgar R Miller, MD (1) · Hertzel Gerstein, M.D. (1) · Ian Lanza, PhD (1) · Ivar Anders Eide, MD, PhD (1)
PMID 19619690, PMID 20451686, PMID 21078810, PMID 21570522, PMID 21844082, PMID 22108152, PMID 22686415, PMID 22686416, PMID 23275364, PMID 23564916, PMID 23656980, PMID 23999452, PMID 24574355, PMID 24684774, PMID 24768457, PMID 24771090, PMID 24898834, PMID 25852206, PMID 26518765, PMID 26631058, PMID 26681720, PMID 27482002, PMID 27974345, PMID 28368516, PMID 28403644, PMID 28424185, PMID 28837885, PMID 28842165, PMID 28895655, PMID 30012324, PMID 30203580, PMID 30262460, PMID 30337280, PMID 30425095, PMID 31235487, PMID 31532795, PMID 31727687, PMID 31928076, PMID 31948661, PMID 32019855, PMID 33752449, PMID 34676424, PMID 35101326, PMID 35431237, PMID 36854916, PMID 36999528, PMID 38747213, PMID 40199888, PMID 40490702
2008 (1), 2016 (1), 5UL1TR000135 (1), KL2TR000136 (1), R01DK088078 (1), R01HL091157 (1), T32DK007352 (1), U24DK100469 (1)